Follow
Patrick McNamara
Patrick McNamara
Professor of Pharmaceutical Sciences, University of Kentucky
Verified email at uky.edu
Title
Cited by
Cited by
Year
Aluminium toxicokinetics: an updated minireview
RA Yokel, PJ McNamara
Pharmacology & Toxicology: MiniReview 88 (4), 159-167, 2001
4902001
Ontogeny of hepatic and renal systemic clearance pathways in infants part I
J Alcorn, PJ McNamara
Clinical pharmacokinetics 41, 959-998, 2002
3212002
Pharmacokinetics in the newborn
J Alcorn, PJ McNamara
Advanced drug delivery reviews 55 (5), 667-686, 2003
3092003
Effects of concentration‐dependent plasma protein binding on ceftriaxone kinetics
K Stoeckel, PJ McNamara, R Brandt, H Plozza‐Nottebrock, WH Ziegler
Clinical Pharmacology & Therapeutics 29 (5), 650-657, 1981
2361981
Protein binding predictions in infants
PJ McNamara, J Alcorn
Aaps Pharmsci 4, 19-26, 2002
2222002
Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction
J Alcorn, X Lu, JA Moscow, PJ McNamara
Journal of Pharmacology and Experimental Therapeutics 303 (2), 487-496, 2002
1852002
Ontogeny of hepatic and renal systemic clearance pathways in infants: part II
J Alcorn, PJ McNamara
Clinical pharmacokinetics 41, 1077-1094, 2002
1822002
Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolism
AJ McLean, PJ McNamara, P DuSouich, M Gibaldi, D Lalka
Clinical Pharmacology & Therapeutics 24 (1), 5-10, 1978
1791978
Apparent volumes of distribution and drug binding to plasma proteins and tissues
M Gibaldi, PJ McNamara
European journal of clinical pharmacology 13 (5), 373-378, 1978
1421978
Entry, Half-Life, and Desferrioxamine-Accelerated Clearance of Brain Aluminum after a Single 26Al Exposure
RA Yokel, SS Rhineheimer, P Sharma, D Elmore, PJ McNamara
Toxicological Sciences 64 (1), 77-82, 2001
1342001
Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology
SL Preston, GL Drusano, P Glue, J Nash, SK Gupta, P McNamara
Antimicrobial agents and chemotherapy 43 (10), 2451-2456, 1999
1331999
Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat
JC Fleishaker, N Desai, PJ McNamara
Journal of pharmaceutical sciences 76 (3), 189-193, 1987
1231987
Should TED talks be teaching us something?
F Romanelli, J Cain, PJ McNamara
American journal of pharmaceutical education 78 (6), 2014
1132014
Serum protein binding and the role of increased alpha 1‐acid glycoprotein in moderately obese male subjects.
IH Benedek, RA Blouin, PJ McNamara
British journal of clinical pharmacology 18 (6), 941-946, 1984
1101984
Endogenous accumulation products and serum protein binding in uremia
PJ McNamara, D Lalka, M Gibaldi
The Journal of Laboratory and Clinical Medicine 98 (5), 730-740, 1981
1101981
Evolution of Ciprofloxacin-Resistant Staphylococcus aureus in In Vitro Pharmacokinetic Environments
JJ Campion, PJ McNamara, ME Evans
Antimicrobial agents and chemotherapy 48 (12), 4733-4744, 2004
1012004
Effect of plasma protein and tissue binding on the biologic half‐life of drugs
M Gibaldi, G Levy, PJ McNamara
Clinical Pharmacology & Therapeutics 24 (1), 1-4, 1978
991978
Active transport of cimetidine into human milk
CY Oo, RJ Kuhn, N Desai, PJ McNamara
Clinical Pharmacology & Therapeutics 58 (5), 548-555, 1995
941995
Serum alpha 1‐acid glycoprotein and the binding of drugs in obesity.
IH Benedek, WD Fiske 3d, WO Griffen, RM Bell, RA Blouin, PJ McNamara
British journal of clinical pharmacology 16 (6), 751-754, 1983
941983
Pharmacodynamic Modeling of Ciprofloxacin Resistance in Staphylococcus aureus
JJ Campion, PJ McNamara, ME Evans
Antimicrobial agents and chemotherapy 49 (1), 209-219, 2005
882005
The system can't perform the operation now. Try again later.
Articles 1–20